|
인쇄하기
취소
|
Biotech products development·efficacy equivalence test concentration
Published: 2001-06-05 06:58:00
Updated: 2001-06-05 06:58:00
The Korea Food and Drug Administration (KFDA) plans to make a concentrated investment in development of biotechnology products and their safety management·efficacy equivalence test management next year.
KFDA settled a draft budget of next year, which was increased to 171,339 million won by 138.7% from this year, and submitted the bill to the Planning and Budget Agency.
KFDA largely increa...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.